![](jpg/gettyimages-1280895783-150x150.jpg)
Ascension
-
2022 Was Hospitals’ Worst Financial Year in Decades, But 2023 Won’t Be Much Better
Financial analysts have said that 2022 may have been the worst year for hospital finances in decades. This year looks like it will be yet another year of financial underperformance, with rural providers in especially dire circumstances.
-
Hospitals, Startups, Health Tech
Providers, tech companies to advocate for expanding clinical care at home
A group of healthcare stakeholders — Amazon Care, Intermountain Healthcare and Ascension, to name a few — has created an alliance to advocate for home-based care services through policy changes.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Google, Ascension expand pilot of health record search tool
After Google struck a controversial partnership with Ascension to build a searchable health record, the companies are now launching an expanded clinical pilot of the tool. Now, about 250 clinicians will be able to use it.
-
Startups, Artificial Intelligence, Health Tech
Medical voice assistant Suki raises $20M
Medical voice assistant startup Suki closed a $20 million funding round. Flare Capital Partners led the round, and co-founder Bill Geary will join Suki’s board.
-
Ascension names first chief community impact officer
As of March 4, Tamarah Duperval-Brownlee holds the newly created role of senior vice president and chief community impact officer at Ascension.
-
Aetna and Ascension join blockchain pilot project for better provider directories
Keeping health plan provider directories current is a major administrative and cost burden for the industry, with an estimated $2.1 billion spent annually across the healthcare system to acquire and maintain provider data.
-
BioPharma, Hospitals, Pharma, SYN
Gates Foundation debuts nonprofit biotech firm at BIO
The Gates Medical Research Institute will develop products for malaria, tuberculosis, enteric and diarrheal diseases.